Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Bacci MR"" wg kryterium: Autor


Wyświetlanie 1-8 z 8
Tytuł:
The impact of lipocalin-type-prostaglandin-D-synthase as a predictor of kidney disease in patients with type 2 diabetes
Autorzy:
Bacci MR
Cavallari MR
de Rozier-Alves RM
Alves BCA
Fonseca FLA
Pokaż więcej
Temat:
Therapeutics. Pharmacology
RM1-950
Źródło:
Drug Design, Development and Therapy, Vol 2015, Iss default, Pp 3179-3182 (2015)
Opis pliku:
electronic resource
Relacje:
http://www.dovepress.com/the-impact-of-lipocalin-type-prostaglandin-d-synthase-as-a-predictor-o-peer-reviewed-article-DDDT; https://doaj.org/toc/1177-8881
Dostęp URL:
https://doaj.org/article/ecc21b8417434a749b18bf5ed7bb9c38  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Hemodialysis and hepatitis B vaccination: a challenge to physicians
Autorzy:
Ayub MA
Bacci MR
Fonseca FL
Chehter EZ
Pokaż więcej
Temat:
Medicine (General)
R5-920
Źródło:
International Journal of General Medicine, Vol 2014, Iss default, Pp 109-114 (2014)
Opis pliku:
electronic resource
Relacje:
http://www.dovepress.com/hemodialysis-and-hepatitis-b-vaccination-a-challenge-to-physicians-a15701; https://doaj.org/toc/1178-7074
Dostęp URL:
https://doaj.org/article/f13229537bc4451aab74020ee8f66d0b  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Endoscopic alterations in a cohort of hemodialysis patients: a cross-sectional study
Autorzy:
Bacci MR
Russo FT
Carvalho GD
Chehter EZ
Jordao VC
Fonseca FL
Pokaż więcej
Temat:
Medicine (General)
R5-920
Źródło:
International Journal of General Medicine, Vol 2014, Iss default, Pp 459-461 (2014)
Opis pliku:
electronic resource
Relacje:
http://www.dovepress.com/endoscopic-alterations-in-a-cohort-of-hemodialysis-patients-a-cross-se-peer-reviewed-article-IJGM; https://doaj.org/toc/1178-7074
Dostęp URL:
https://doaj.org/article/5cf70435ac1d44b9b6a332b6160b8ccf  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Value of Diaphragm Ultrasonography for Extubation: A Single-Blinded Randomized Clinical Trial.
Autorzy:
Toledo TG; Centro Universitario FMABC, Santo Andre, Brazil.
Bacci MR; Centro Universitario FMABC, Santo Andre, Brazil.
Pokaż więcej
Źródło:
Critical care research and practice [Crit Care Res Pract] 2023 Sep 19; Vol. 2023, pp. 8403971. Date of Electronic Publication: 2023 Sep 19 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Ribavirin aerosol in hospitalized adults with respiratory distress and COVID-19: An open-label trial.
Autorzy:
Poulakou G; Third Department of Internal Medicine, 'Sotiria' General Hospital of Chest Diseases, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
Barakat M; Bausch Health, Laval, Quebec, Canada.
Israel RJ; Bausch Health, Bridgewater, New Jersey, USA.
Bacci MR; Clinical Analysis Division, Praxis Pesquisa Medica, Centro Universitário Faculdade de Medicina do ABC, Santo Andre, São Paulo, Brazil.
Pokaż więcej
Corporate Authors:
Virazole Collaborator Group for COVID-19 Respiratory Distress
Źródło:
Clinical and translational science [Clin Transl Sci] 2023 Jan; Vol. 16 (1), pp. 165-174. Date of Electronic Publication: 2022 Nov 03.
Typ publikacji:
Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*
Respiratory Distress Syndrome*/drug therapy
Male ; Humans ; Adult ; Middle Aged ; Female ; Ribavirin/therapeutic use ; SARS-CoV-2 ; Respiratory Aerosols and Droplets ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
Autorzy:
Urwyler P; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.
Charitos P; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.
Moser S; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.
Heijnen IAFM; Division of Medical Immunology, Laboratory Medicine, University Hospital Basel, Basel, Switzerland.
Trendelenburg M; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.; Department of Clinical Research and Department of Biomedicine, University of Basel, Basel, Switzerland.
Thoma R; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Sumer J; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Camacho-Ortiz A; Hospital Universitario Dr. José Eleuterio González, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Bacci MR; Department of General Practice, Centro Universitário em Saúde do ABC, Santo André, SP, Brazil.
Huber LC; Clinic for Internal Medicine, City Hospital Triemli, Zurich, Switzerland.
Stüssi-Helbling M; Clinic for Internal Medicine, City Hospital Triemli, Zurich, Switzerland.
Albrich WC; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Sendi P; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.; Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
Osthoff M; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland. .; Department of Clinical Research and Department of Biomedicine, University of Basel, Basel, Switzerland. .
Pokaż więcej
Źródło:
Trials [Trials] 2021 Jan 04; Vol. 22 (1), pp. 1. Date of Electronic Publication: 2021 Jan 04.
Typ publikacji:
Clinical Trial Protocol; Letter
MeSH Terms:
COVID-19 Drug Treatment*
Complement C1 Inhibitor Protein/*administration & dosage
SARS-CoV-2/*isolation & purification
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Brazil ; COVID-19/blood ; COVID-19/diagnosis ; COVID-19/virology ; Clinical Trials, Phase II as Topic ; Complement C1 Inhibitor Protein/adverse effects ; Complement C1 Inhibitor Protein/pharmacokinetics ; Drug Administration Schedule ; Female ; Humans ; Injections, Intravenous/methods ; Male ; Mexico ; Middle Aged ; Multicenter Studies as Topic ; Pilot Projects ; Randomized Controlled Trials as Topic ; Recombinant Proteins/administration & dosage ; Recombinant Proteins/adverse effects ; Recombinant Proteins/pharmacokinetics ; Severity of Illness Index ; Switzerland ; Treatment Outcome ; Young Adult
Opinia redakcyjna
Tytuł:
Urinary beta-trace protein gene expression analysis in type 2 diabetes mellitus patients.
Autorzy:
Bacci MR; Faculdade de Medicina do ABC, Santo André, SP, Brazil.
Alves BDCA; Faculdade de Medicina do ABC, Santo André, SP, Brazil.
Cavallari MR; Faculdade de Medicina do ABC, Santo André, SP, Brazil.
Azzalis LA; Universidade Federal de São Paulo, Diadema, SP, Brazil.
Rozier-Alves RM; Faculdade de Medicina do ABC, Santo André, SP, Brazil.
Perez MM; Faculdade de Medicina do ABC, Santo André, SP, Brazil.
Chehter EZ; Faculdade de Medicina do ABC, Santo André, SP, Brazil.
Pereira EC; Universidade Federal de São Paulo, Diadema, SP, Brazil.
Fonseca FLA; Faculdade de Medicina do ABC, Santo André, SP, Brazil.; Universidade Federal de São Paulo, Diadema, SP, Brazil.
Pokaż więcej
Źródło:
Einstein (Sao Paulo, Brazil) [Einstein (Sao Paulo)] 2017 Oct-Dec; Vol. 15 (4), pp. 441-444.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2/*urine
Intramolecular Oxidoreductases/*genetics
Intramolecular Oxidoreductases/*urine
Lipocalins/*genetics
Lipocalins/*urine
Adult ; Area Under Curve ; Blood Glucose/metabolism ; Case-Control Studies ; Cross-Sectional Studies ; Diabetes Mellitus, Type 2/genetics ; Female ; Gene Expression ; Glomerular Filtration Rate ; Humans ; Intramolecular Oxidoreductases/blood ; Kidney/metabolism ; Lipocalins/blood ; Male ; Middle Aged ; ROC Curve ; Sensitivity and Specificity
Czasopismo naukowe
    Wyświetlanie 1-8 z 8

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies